The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts

By Newsfeedback@Fool Com (Alex Carchidi)5 days ago

It's no secret that in-person medical appointments are hard to come by in the age of COVID-19. But now that the U.S. appears to be getting the pandemic under control, people are eagerly flocking back to the clinic for everything they've put off, from dental cleanings to heart surgery.

Okay, perhaps some aren't exactly thrilled to be catching up on their deferred healthcare, but the ongoing influx of business is certainly going to drive the next few quarters of earnings across the industry. And, luckily for investors, there is a pair of reliable and rapidly growing medical device companies that are poised to benefit in a big way. Though neither of the two stocks are cheap at their present valuations, both could soar higher as life gets back on track, and that makes them worth a closer look.


Image source: Getty Images

1. Align Technologies

When the pandemic hit, cosmetic dentistry ground to a halt, and that gave Align Technologies (NASDAQ:ALGN) a rough start to 2020. The company makes the Invisalign brand of transparent tooth straighteners, each of which is individually shaped to fit for all of its nine million patients by an army of nearly 190,000 expert orthodontists.

In the second quarter of 2020, it moved only 221,900 cases of its straighteners, compared to 359,400 cases in the prior three months. While its business quickly recovered and ended the year on a high note of 568,000 cases sold in the final quarter, there's no way around the fact that patients need to attend in-person consultations with their doctor before starting to use teeth aligners.

Continue read on